explore -WSS

explore

author：comprehensive 2025-09-28 21:11:41 - browse：7981

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： 23andMe had bad news about my health. I wish a person had delivered it

WSS

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Ebola: Gilead Sciences antiviral shows promise as new treatment

Why scientists need input from humanists on sensitive research

FDA advisers back CAR

HHS secretary Becerra pressed on Change HealthCare cyberattack

Novavax promises a turnaround & Lilly roils the obesity market

Wikipedia

explore

focus

Peter Hotez and the public health issue of online harassment

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

ChatGPT in medicine: STAT answers readers' burning questions

UCLA team creates talking throat patch for voice disorders

What does generative AI mean for health care? We asked experts

Readout Newsletter: CAR

Walensky prepares to leave CDC — and Congress — behind

Affirmative action in medical school literally saved lives

Anesthesiologist group: stop taking Ozempic before surgery

HHS secretary Becerra pressed on Change HealthCare cyberattack

focus

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Hepatitis C has a cure — but many Americans still lack access to it

23andMe had bad news about my health. I wish a person had delivered it

FDA advisers back CAR

United colonoscopy coverage change 'may cost lives,' doctors say

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

entertainment

knowledge

focus

entertainment